SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
John Hancock Premium Dividend Fund (PDT) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 60/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — PDT
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio7.31
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$1.82
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$2.13 |
$62.11M |
$102.92M |
165.7% |
| 2017 |
$1.25 |
$62.76M |
$60.29M |
96.1% |
| 2018 |
$0.08 |
$6.23M |
$4.18M |
67.2% |
| 2019 |
$2.61 |
$128.38M |
$126.4M |
98.5% |
| 2020 |
$-1.70 |
$-80.68M |
$-82.45M |
- |
| 2021 |
$3.23 |
$159.35M |
$157.56M |
98.9% |
| 2022 |
$-1.12 |
$-52.88M |
$-54.58M |
- |
| 2023 |
$-0.91 |
$-42.95M |
$-44.67M |
- |
| 2024 |
$4.00 |
$198.3M |
$196.58M |
99.1% |
| 2025 |
$0.00 |
$89.58M |
$68.47M |
76.4% |
